Call Our HELPLINE: 1-800-4PD-INFO (473-4636)

Fourth Annual Celebrate Spring Boston Raises $50,000 for Parkinson’s Disease Foundation

Boston Area Women Inspire Fellow Young Professionals to End Parkinson’s

Young professionals in Boston, MA, led by Rehana Ashraf, Kate Evans and Anne Greene raised $50,000 for Parkinson’s research at the fourth annual Celebrate Spring Boston at The Liberty Hotel on April 29. They welcomed 180 guests, including New England Patriots alumni, to the event to benefit the Parkinson’s Disease Foundation (PDF).

Measured by net proceeds, this year's Celebrate Spring Boston was most successful yet, bringing the amount raised over four years for PDF research programs to $180,000.  Guests, including former New England Patriots players Harold Shaw, Jon Williams and Garin Veris, enjoyed an evening of cocktails, hors d’oeuvres, music, dancing and a silent auction.  The event Co-chairs say their goals are to advance research and motivate their generation to join PDF in ending the disease.

“Kate, Anne and I are driven to help end Parkinson’s in honor of our loved ones, including my late father. We know that our generation is an important part of the team that will move the Parkinson’s Disease Foundation closer to a cure. We are grateful for the tremendous response from young professionals in Boston who help make this event a success by advancing Parkinson’s research,” says Ms. Ashraf.

Event proceeds benefit the work of PDF Research Fellow, Nan Li, Ph.D., of the Massachusetts Institute of Technology.  Dr. Li, who is using cutting-edge imaging technology to study Parkinson’s, is supported through a PDF fellowship program designed to keep talented young scientists in the field. 

About Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder that affects nearly one million people in the US.  Although promising research is being conducted, there is currently no cure for Parkinson’s.

Tuesday, May 3, 2016
Parkinson's Foundation Study Finds Gender Disparities in Caregiving, with Women at a Disadvantage
Monday, December 4, 2017

Largest Clinical Study Tracking Parkinson’s Patients Over Time Shows Women with Parkinson’s Have Fewer Caregiving Resources than Men with Parkinson’s

Parkinson’s Foundation Invests $60,000 to Develop Innovative Models of Patient Engagement
Wednesday, November 29, 2017

Six Awards Foster Patient-Driven Parkinson’s Research

Jesse Jackson Diagnosed with Parkinson's Disease
Friday, November 17, 2017

Rev. Jesse Jackson’s announcement today that he has been living with Parkinson’s Disease since 2015 further proves that receiving a diagnosis of Parkinson's is not a death sentence. There are many ways that people living with Parkinson's can control the symptoms of the disease with exercise and physical therapy to help maintain mobility and balance.

Update on Tozadenant Trial for Parkinson’s
Thursday, November 16, 2017

On 11/20/17, Acorda Therapeutics, Inc. announced that it is discontinuing the tozadenant clinical trial.  They concluded that they could not be confident that weekly white blood cell count screening would sufficiently ensure patient safety.

Parkinson’s Foundation Adds Marcia Mondavi Borger to Board of Directors
Tuesday, November 14, 2017

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Marcia Mondavi Borger to its Board of Directors.

Parkinson’s Foundation and Melvin Yahr International Parkinson’s Disease Foundation Announce Merger
Thursday, October 26, 2017

Parkinson’s Foundation Establishes ‘Dr. Melvin Yahr Research Award’ to Fund Neurology Fellows, Promote Leadership Diversity in Parkinson’s Research

Parkinson’s Foundation Welcomes Two New Board Members
Tuesday, October 24, 2017

Peter Goldman and Joshua Raskin Join Board of Directors

NEW YORK & MIAMI — The Parkinson’s Foundation today announced the election of Chicago entrepreneur Peter Goldman and New York financial analyst Joshua Raskin to its Board of Directors.

Parkinson's Foundation Unveils New Brand and Website
Thursday, October 19, 2017

NEW YORK and MIAMI /PRNewswire-USNewswire/ — The Parkinson's Foundation today announced the launch of its new brand and website following the recent merger of two legacy organizations – National Parkinson Foundation and Parkinson's Disease Foundation – as part of its mission to

FDA Approves Extended-Release Amantadine (GOCOVRI™) for Treatment of Dyskinesia
Friday, August 25, 2017

Statement from the Parkinson's Foundation Medical Director, Michael Okun, MD

Parkinson’s Foundation Announces $1.2 Million Investment to Advance Careers, Support Innovation of Early Career Parkinson’s Scientists
Tuesday, August 8, 2017

NEW YORK & MIAMI The Parkinson's Foundation is pleased to announce a $1.2 million investment in 27 career development and fellowship grants to support the work of promising early career scientists in the field of Parkinson's.


mail icon

Subscribe to get the latest news on treatments, research and other updates.